(Q37524755)

English

Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010).

scientific article published on October 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010). (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

bipolar disorder

1 reference

based on heuristic

inferred from title

metabolic syndrome

1 reference

based on heuristic

inferred from title

author name string

David E Kemp

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

James M Eudicone

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Robert D McQuade

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jessie S Chambers

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ross A Baker

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

1 October 2010

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Journal of Clinical Psychopharmacology

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

30

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

631-634

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

23 August 2017

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

23 August 2017

Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

23 August 2017

Translating scientific opportunity into public health impact: a strategic plan for research on mental illness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

14 September 2017

Metabolic syndrome: a follow-up study of acute depressive inpatients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

2 September 2018

Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

2 September 2018

A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

2 September 2018

Metabolic syndrome in patients with bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

2 September 2018

Visceral fat, waist circumference, and BMI: impact of race/ethnicity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

2 September 2018

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

2 September 2018

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3904751

2 September 2018

Moderators of treatment outcomes: clinical, research, and policy importance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20841962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/JCP.0B013E3181F0569F

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

release_eebwwxjnkvd3xofwahqktloi4m

1 reference

https://api.fatcat.wiki/v0/release/eebwwxjnkvd3xofwahqktloi4m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37524755&oldid=1843792314"